SCHEDULE 13G

Statement of Beneficial Ownership

Cellectar Biosciences, Inc. Filed 2026-08-04 Acc 0000919574-26-004748

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-08-13 SCHEDULE 13G Statement of Beneficial Ownership
2026-08-04 SCHEDULE 13G Statement of Beneficial Ownership
2026-06-05 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)